Interestingly, PGRN expression does not directly correlate with the gray matter atrophy patterns in symptomatic FTD patients' brains [115], suggesting complex regulatory mechanisms beyond PGRN levels alone. This evidence concerns the gene GRN and frontotemporal dementia.